Anthony M. Coates

St George's University Of London
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

The Role of Combination Antibiotic Therapy in Combatting Drug-Resistant Acinetobacter baumannii Infections: A Systematic Review of Randomised Control Trials.

The Role of Combination Antibiotic Therapy in Combatting Drug-Resistant Acinetobacter baumannii Infections: A Systematic Review of Randomised Control Trials.

Journal: Antibiotics (Basel, Switzerland)

Published: February 11, 2026

Characterisation of Ferritin-Lymphocyte Ratio in COVID-19.

Characterisation of Ferritin-Lymphocyte Ratio in COVID-19.

Journal: Biomedicines

Published: September 17, 2023

Low CRB-65 Scores Effectively Rule out Adverse Clinical Outcomes in COVID-19 Irrespective of Chest Radiographic Abnormalities.

Low CRB-65 Scores Effectively Rule out Adverse Clinical Outcomes in COVID-19 Irrespective of Chest Radiographic Abnormalities.

Journal: Biomedicines

Published: July 31, 2023

Effective prognostic and clinical risk stratification in COVID-19 using multimodality biomarkers.

Effective prognostic and clinical risk stratification in COVID-19 using multimodality biomarkers.

Journal: Journal of internal medicine

Published: April 28, 2023

Comparison of Lymphocyte-CRP Ratio to Conventional Inflammatory Markers for Predicting Clinical Outcomes in COVID-19.

Comparison of Lymphocyte-CRP Ratio to Conventional Inflammatory Markers for Predicting Clinical Outcomes in COVID-19.

Journal: Journal of personalized medicine

Published: April 21, 2023

Normal high-sensitivity cardiac troponin for ruling-out inpatient mortality in acute COVID-19.

Normal high-sensitivity cardiac troponin for ruling-out inpatient mortality in acute COVID-19.

Journal: PloS one

Published: October 21, 2022

The Efficacy of Using Combination Therapy against Multi-Drug and Extensively Drug-Resistant Pseudomonas aeruginosa in Clinical Settings.

The Efficacy of Using Combination Therapy against Multi-Drug and Extensively Drug-Resistant Pseudomonas aeruginosa in Clinical Settings.

Journal: Antibiotics (Basel, Switzerland)

Published: January 18, 2022

Zidovudine enhances activity of carbapenems against NDM-1-producing Enterobacteriaceae.

Zidovudine enhances activity of carbapenems against NDM-1-producing Enterobacteriaceae.

Journal: The Journal of antimicrobial chemotherapy

Published: March 03, 2021

Mefloquine enhances the activity of colistin against antibiotic-resistant Enterobacterales in vitro and in an in vivo animal study.

Mefloquine enhances the activity of colistin against antibiotic-resistant Enterobacterales in vitro and in an in vivo animal study.

Journal: International journal of antimicrobial agents

Published: October 07, 2020

Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction.

Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction.

Journal: Expert review of anti-infective therapy

Published: December 19, 2019

A model-based analysis identifies differences in phenotypic resistance between in vitro and in vivo: implications for translational medicine within tuberculosis.

A model-based analysis identifies differences in phenotypic resistance between in vitro and in vivo: implications for translational medicine within tuberculosis.

Journal: Journal of pharmacokinetics and pharmacodynamics

Published: December 06, 2019

Antimicrobial Activity of the Quinoline Derivative HT61 against Staphylococcus aureus Biofilms.

Antimicrobial Activity of the Quinoline Derivative HT61 against Staphylococcus aureus Biofilms.

Journal: Antimicrobial agents and chemotherapy

Published: October 21, 2019

Showing 1-12 of 49

Last Updated: 09/26/2026